AU469986B2 - Sulfobenzylpenicillin salts - Google Patents

Sulfobenzylpenicillin salts

Info

Publication number
AU469986B2
AU469986B2 AU57600/73A AU5760073A AU469986B2 AU 469986 B2 AU469986 B2 AU 469986B2 AU 57600/73 A AU57600/73 A AU 57600/73A AU 5760073 A AU5760073 A AU 5760073A AU 469986 B2 AU469986 B2 AU 469986B2
Authority
AU
Australia
Prior art keywords
sulfobenzylpenicillin
salts
sulfobenzylpenicillin salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU57600/73A
Other languages
English (en)
Other versions
AU5760073A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU5760073A publication Critical patent/AU5760073A/en
Application granted granted Critical
Publication of AU469986B2 publication Critical patent/AU469986B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU57600/73A 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts Expired AU469986B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (US20100154141A1-20100624-C00001.png) 1972-07-01 1972-07-01
JPJP66301/72 1972-07-01

Publications (2)

Publication Number Publication Date
AU5760073A AU5760073A (en) 1975-01-09
AU469986B2 true AU469986B2 (en) 1976-02-26

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57600/73A Expired AU469986B2 (en) 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts

Country Status (15)

Country Link
US (1) US3925357A (US20100154141A1-20100624-C00001.png)
JP (1) JPS5512435B2 (US20100154141A1-20100624-C00001.png)
AT (1) AT325206B (US20100154141A1-20100624-C00001.png)
AU (1) AU469986B2 (US20100154141A1-20100624-C00001.png)
BE (1) BE801588A (US20100154141A1-20100624-C00001.png)
CA (1) CA996548A (US20100154141A1-20100624-C00001.png)
CH (1) CH573435A5 (US20100154141A1-20100624-C00001.png)
CS (1) CS168036B2 (US20100154141A1-20100624-C00001.png)
DE (1) DE2332840A1 (US20100154141A1-20100624-C00001.png)
FR (1) FR2190414B1 (US20100154141A1-20100624-C00001.png)
GB (1) GB1386566A (US20100154141A1-20100624-C00001.png)
HU (1) HU166029B (US20100154141A1-20100624-C00001.png)
NL (1) NL7308048A (US20100154141A1-20100624-C00001.png)
PL (1) PL92969B1 (US20100154141A1-20100624-C00001.png)
SE (1) SE402916B (US20100154141A1-20100624-C00001.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (US20100154141A1-20100624-C00001.png) * 1978-07-29 1980-02-13
HU230382B1 (hu) * 2001-02-24 2016-03-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
NZ619413A (en) 2006-05-04 2015-08-28 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
AR071175A1 (es) * 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
CA2735562C (en) * 2008-08-15 2017-10-17 Boehringer Ingelheim International Gmbh Dpp-4 inhibitors for wound healing
RU2011113823A (ru) 2008-09-10 2012-10-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP2012512848A (ja) 2008-12-23 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 有機化合物の塩の形態
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
BR112012028136A2 (pt) 2010-05-05 2016-08-09 Boehringer Ingelheim Int terapia de combinaçao
EP3725325B1 (en) 2010-06-24 2023-05-31 Boehringer Ingelheim International GmbH Diabetes therapy
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
CN103781788B (zh) 2011-07-15 2016-08-17 勃林格殷格翰国际有限公司 经取代的喹唑啉、其制备及其在药物组合物中的用途
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
MX2018015089A (es) 2016-06-10 2019-05-13 Boehringer Ingelheim Int Combinacion de linagliptina y metformina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (US20100154141A1-20100624-C00001.png) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
JPS4925121A (US20100154141A1-20100624-C00001.png) 1974-03-06
SE402916B (sv) 1978-07-24
JPS5512435B2 (US20100154141A1-20100624-C00001.png) 1980-04-02
PL92969B1 (US20100154141A1-20100624-C00001.png) 1977-04-30
FR2190414B1 (US20100154141A1-20100624-C00001.png) 1976-07-02
NL7308048A (US20100154141A1-20100624-C00001.png) 1974-01-03
CS168036B2 (US20100154141A1-20100624-C00001.png) 1976-05-28
FR2190414A1 (US20100154141A1-20100624-C00001.png) 1974-02-01
AT325206B (de) 1975-10-10
DE2332840A1 (de) 1974-01-17
HU166029B (US20100154141A1-20100624-C00001.png) 1974-12-28
CA996548A (en) 1976-09-07
GB1386566A (en) 1975-03-12
BE801588A (fr) 1973-12-28
AU5760073A (en) 1975-01-09
US3925357A (en) 1975-12-09
CH573435A5 (US20100154141A1-20100624-C00001.png) 1976-03-15

Similar Documents

Publication Publication Date Title
AU469986B2 (en) Sulfobenzylpenicillin salts
AU454372B2 (en) Childsafe actuator-overcap
AU470375B2 (en) Substituted w-pentanorprostaglandins
AU5996573A (en) Pyridinium salts
CA980352A (en) Substituted aminohalopyridines
CA950831A (en) Biocidal salts
CA971622A (en) Gererateur electrochimique
CA995666A (en) 1-amino-pyridinium salts
AU5709473A (en) S-substituted-2-thiodenosines
CA991191A (en) Cycloamidines
CA1010049A (en) N-acyl-o-hydrocarbylphosphoroamidothioate salts
CA983062A (en) Paper-stacker
CA991638A (en) Substituted 3-cyanobenzenesulfonamides
CA962268A (en) Cycloalkyllactamimides
CA961605A (en) Bed-settee
AU5090373A (en) 5-aroyl-furans
AU472956B2 (en) Substituted benzodioxoles
CA991629A (en) Tetra-t-docecylmercapto-p-benzoquinone
CA995680A (en) Substituted 2-benzoyloxazolidines
AU4575372A (en) 2-acyl-5-nitrothiazoles
CA893696A (en) Amcyclodin salts
CA913109A (en) Thienyliodonium salts
CA907019A (en) N-tritylimidazolium salts
AU491554B1 (en) Pyridinium salts
CA905407A (en) Substituted 3-aminoindazoles